XML 75 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Compensatory Equity Incentive Plan and Other Equity Incentives (Tables)
12 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of share based compensation award plans

Equity Compensation Arrangement

  Award Shares Authorized    

Outstanding at

June 30,

2020

   

Available for Issuance at June 30,

2020

 
SICP (or Omnibus Plan)     5,115,625       3,262,426       930,326  
2014 ESPP     400,000             306,600  
      5,515,625       3,262,426       1,236,926  
Schedule of stock options fair value assumptions
    Year Ended June 30,  
    2020     2019  
Weighted-average expected volatility     64.4 %     69.5 %
Dividend yields     0 %     0 %
Weighted-average risk-free interest rate     1.53 %     3.00 %
Weighted-average expected term, in years     6.93       7.50  
Schedule of share-based payment awards activity

      Stock Options         Restricted Stock Units (RSUs)  
          Weighted-     Weighted-           Weighted-  
          Average     Average           Average  
          Exercise     Remaining           Remaining  
     Shares      Price      Contract      Shares      Contract  
June 30, 2018     1,005,129     $ 1.77       6.3       1,649,353       0.9  
                                         
Granted     13,058     $ 2.10       9.4       229,509       2.4  
Exercised     (17,610 )   $ 1.08               (14,336 )        
Cancelled/Forfeited     (20,652 )   $ 1.17                        
June 30, 2019     979,925     $ 1.80       5.5       1,864,526       0.9  
                                         
Granted     314,817     $ 1.60       9.6       484,000       2.4  
Exercised     (29,356 )   $ 1.35               (17,204 )        
Cancelled/Forfeited     (322,811 )   $ 2.08               (11,471 )        
June 30, 2020     942,575     $ 1.65       6.5       2,319,851       0.9  
                                         
Awards exercisable/                                        
vested as of                                        
June 30, 2020     676,293     $ 1.63       5.3       1,650,325        
                                         
Awards unexercisable/                                        
unvested as of                                        
June 30, 2020     266,282     $ 1.70       9.6       669,526       0.9  
      942,575                       2,319,851          

 

Schedule of share-based compensation future cost to be recognized
    Stock              
Fiscal Year Ending:   Options     RSUs     Total  
June 30, 2021   $ 59,572     $ 271,867     $ 331,439  
June 30, 2022     55,654       148,543       204,197  
June 30, 2023     62,517       68,704       131,221  
June 30, 2024     46,945       40,539       87,484  
    $ 224,688     $ 529,653     $ 754,341  
Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards
Unexercisable/Unvested Awards     Stock Options Shares       RSU Shares       Total Shares      Weighted-Average Grant Date Fair Values (per share)  
June 30, 2018     218,419       361,983       580,402     $ 1.53  
Granted     13,058       229,509       242,567     $ 1.80  
Vested     (118,282 )     (191,348 )     (309,630 )   $ 1.79  
Cancelled/Forfeited     (2,500 )     -       (2,500 )   $ 0.97  
June 30, 2019     110,695       400,144       510,839     $ 2.09  
Granted     314,817       484,000       798,817     $ 0.79  
Vested     (99,151 )     (203,147 )     (302,298 )   $ 1.78  
Cancelled/Forfeited     (60,079 )     (11,471 )     (71,550 )   $ 2.70  
June 30, 2020     266,282       669,526       935,808     $ 1.10  
Schedule of total stock-based compensation expense included in the consolidated statements of comprehensive income
    Year Ended June 30,  
    2020     2019  
             
Stock options   $ (59,019 )   $ 36,461  
RSUs     309,757       358,329  
     Total   $ 250,738     $ 394,790  
                 
The amounts above were included in:                
Selling, general & administrative   $ 250,738     $ 393,352  
Cost of sales     -       1,620  
New product development     -       (182 )
    $ 250,738     $ 394,790